Efficacy and Safety of Neoadjuvant Monoimmunotherapy With PD-1 Inhibitor for dMMR/MSIâH Locally Advanced Colorectal Cancer: A Single-Center Real-World Study.
Front Immunol
; 13: 913483, 2022.
Article
in En
| MEDLINE
| ID: mdl-35958603
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colonic Neoplasms
/
Neoadjuvant Therapy
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Front Immunol
Year:
2022
Document type:
Article
Affiliation country:
China
Country of publication:
Switzerland